TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2007
State/Territory | Current | Active | ||||||
---|---|---|---|---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
Alaska | 97 | 51.2 | 7.9 | (35.7 – 66.7) | 114 | 48.0 | 7.0 | (34.3 – 61.7) |
Arizona | 165 | 48.4 | 6.7 | (35.3 – 61.5) | 179 | 44.1 | 6.5 | (31.4 – 56.8) |
California | 197 | 55.0 | 4.7 | (45.8 – 64.2) | 216 | 46.7 | 5.5 | (35.9 – 57.5) |
Colorado | 269 | 44.7 | 4.4 | (36.1 – 53.3) | 291 | 44.1 | 4.1 | (36.1 – 52.1) |
Connecticut | 268 | 47.7 | 5.3 | (37.3 – 58.1) | 288 | 46.1 | 5.1 | (36.1 – 56.1) |
District of Columbia | 119 | 45.6 | 6.1 | (33.6 – 57.6) | 134 | 39.2 | 5.5 | (28.4 – 50.0) |
Florida | 603 | 51.8 | 5.0 | (42.0 – 61.6) | 656 | 45.4 | 4.8 | (36.0 – 54.8) |
Georgia | 267 | 37.2 | 4.0 | (29.4 – 45.0) | 301 | 34.8 | 3.8 | (27.4 – 42.2) |
Hawaii | 303 | 48.0 | 4.4 | (39.4 – 56.6) | 309 | 48.2 | 4.4 | (39.6 – 56.8) |
Illinois | 209 | 48.0 | 4.6 | (39.0 – 57.0) | 228 | 42.9 | 4.4 | (34.3 – 51.5) |
Indiana | 305 | 56.0 | 4.2 | (47.8 – 64.2) | 319 | 56.0 | 3.9 | (48.4 – 63.6) |
Iowa | 205 | 50.2 | 4.9 | (40.6 – 59.8) | 221 | 47.6 | 4.7 | (38.4 – 56.8) |
Kansas | 403 | 48.6 | 4.2 | (40.4 – 56.8) | 425 | 50.7 | 4.0 | (42.9 – 58.5) |
Maine | 372 | 53.6 | 4.1 | (45.6 – 61.6) | 389 | 51.8 | 4.0 | (44.0 – 59.6) |
Maryland | 298 | 49.0 | 4.2 | (40.8 – 57.2) | 337 | 43.6 | 3.9 | (36.0 – 51.2) |
Massachusetts | 180 | 44.1 | 6.4 | (31.6 – 56.6) | 197 | 42.5 | 6.0 | (30.7 – 54.3) |
Michigan | 401 | 60.3 | 3.8 | (52.9 – 67.7) | 440 | 56.2 | 3.6 | (49.1 – 63.3) |
Missouri | 248 | 64.9 | 4.5 | (56.1 – 73.7) | 249 | 66.9 | 4.6 | (57.9 – 75.9) |
Montana | 245 | 50.5 | 5.0 | (40.7 – 60.3) | 252 | 48.0 | 5.1 | (38.0 – 58.0) |
Nebraska | 422 | 52.5 | 5.6 | (41.5 – 63.5) | 442 | 50.8 | 5.2 | (40.6 – 61.0) |
Nevada | 204 | 50.3 | 5.6 | (39.3 – 61.3) | 224 | 47.5 | 5.3 | (37.1 – 57.9) |
New Hampshire | 231 | 53.1 | 4.5 | (44.3 – 61.9) | 249 | 51.4 | 4.3 | (43.0 – 59.8) |
New Mexico | 244 | 65.2 | 4.1 | (57.2 – 73.2) | 282 | 58.0 | 4.3 | (49.6 – 66.4) |
New York | 285 | 52.8 | 4.0 | (45.0 – 60.6) | 317 | 48.9 | 3.9 | (41.3 – 56.5) |
Ohio | 408 | 45.7 | 4.5 | (36.9 – 54.5) | 441 | 43.2 | 4.0 | (35.4 – 51.0) |
Oklahoma | 281 | 54.2 | 4.4 | (45.6 – 62.8) | 287 | 53.0 | 4.3 | (44.6 – 61.4) |
Oregon | 314 | 50.5 | 4.5 | (41.7 – 59.3) | 340 | 47.6 | 4.2 | (39.4 – 55.8) |
Pennsylvania | 217 | 56.9 | 5.5 | (46.1 – 67.7) | 246 | 53.1 | 5.1 | (43.1 – 63.1) |
Texas | 266 | 40.5 | 5.2 | (30.3 – 50.7) | 292 | 41.9 | 4.5 | (33.1 – 50.7) |
Utah | 219 | 47.9 | 4.5 | (39.1 – 56.7) | 232 | 44.7 | 4.3 | (36.3 – 53.1) |
Vermont | 383 | 51.3 | 3.5 | (44.4 – 58.2) | 402 | 50.8 | 3.3 | (44.3 – 57.3) |
Washington | 1,540 | 58.2 | 2.1 | (54.1 – 62.3) | 1,698 | 55.1 | 2.0 | (51.2 – 59.0) |
West Virginia | 256 | 53.8 | 4.4 | (45.2 – 62.4) | 264 | 54.1 | 4.2 | (45.9 – 62.3) |
Wisconsin | 234 | 62.0 | 5.0 | (52.2 – 71.8) | 262 | 54.8 | 5.5 | (44.0 – 65.6) |
34 areas total | 10,658 | 51.3 | 1.2 | (48.9 – 53.7) | 11,523 | 47.7 | 1.2 | (45.3 – 50.1) |
Median | 50.9 | 48.0 | ||||||
Range | 37.2-65.2 | 34.8-66.9 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval